Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33874067)
Watch
English
Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
title
Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
author name string
Rajiv Mahajan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
language of work or name
English
0 references
publication date
1 August 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
published in
Indian Journal of Pharmacology
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
volume
41
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
issue
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
page(s)
197-198
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
Identifiers
DOI
10.4103/0253-7613.56070
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
PMCID
2875741
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
PubMed ID
20523873
1 reference
stated in
Europe PubMed Central
PubMed ID
20523873
retrieved
29 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
